Production of Useful Terpenoids by Higher-Fungus Cell Factory and Synthetic Biology Approaches

Trends in Biotechnology

Volumn 34, Issue 3, 2016, Pages 242-255

  Xiao, Han ^a   Zhong, Jian Jiang ^a  

^a Shanghai Jiao Tong University   (China)

Author keywords

Biochemical engineering; Cell factory; Higher fungus; Metabolic engineering; Synthetic biology; Terpenoid production

Indexed keywords

BIOCHEMICAL ENGINEERING; CELLS; CYTOLOGY; FUNGI; HEALTH CARE; LIPIDS; METABOLIC ENGINEERING; MOLECULAR BIOLOGY;

GENETIC BACKGROUNDS; GENETIC MANIPULATIONS; HEALTHCARE INDUSTRY; INDUSTRIAL COMMUNITIES; NATURAL COMPOUNDS; STATE OF THE ART; SYNTHETIC BIOLOGY; TERPENOIDS;

CELL ENGINEERING;

NATURAL PRODUCT; TERPENOID DERIVATIVE; TERPENE;

FUNGAL CELL; GENETIC MANIPULATION; GENETIC TRANSFORMATION; HOST PATHOGEN INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNTHESIS; SYNTHETIC BIOLOGY; FUNGUS; GENETICS; METABOLIC ENGINEERING; METABOLISM;

FUNGI; METABOLIC ENGINEERING; SYNTHETIC BIOLOGY; TERPENES;

EID: 84958729519     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2015.12.007     Document Type: Review

References (91)

1. Zhang L. Secondary metabolites and bioactivities from higher fungi in China. Mini Rev. Med. Chem. 2015, 15:157-177.
2. Qin H., et al. Cell factories of higher fungi for useful metabolite production. Adv. Biochem. Eng. Biotechnol. 2016, 155:199-235.
3. Thomas J.P., et al. Phase I clinical and pharmacokinetic trial of irofulven. Cancer Chemother. Pharmacol. 2001, 48:467-472.
4. Seiden M.V., et al. A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. Gynecol. Oncol. 2006, 101:55-61.
5. Yan K., et al. Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes. Antimicrob. Agents Chemother. 2006, 50:3875-3881.
6. Tang Y.Z., et al. Pleuromutilin and its derivatives - the lead compounds for novel antibiotics. Mini Rev. Med. Chem. 2012, 12:53-61.
7. Tang W., et al. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci. 2006, 80:205-211.
8. Xu J.W., et al. Enhancement of ganoderic acid accumulation by overexpression of an N-terminally truncated 3-hydroxy-3-methylglutaryl coenzyme A reductase gene in the basidiomycete Ganoderma lucidum. Appl. Environ. Microbiol. 2012, 78:7968-7976.
9. Xu J.W., et al. Production of individual ganoderic acids and expression of biosynthetic genes in liquid static and shaking cultures of Ganoderma lucidum. Appl. Microbiol. Biotechnol. 2010, 85:941-948.
10. Zhang Y.H.P., Huang W.D. Constructing the electricity-carbohydrate-hydrogen cycle for a sustainability revolution. Trends Biotechnol. 2012, 30:301-306.
11. Zhu Z., et al. A high-energy-density sugar biobattery via a synthetic enzymatic pathway. Nat. Commun. 2014, 5:3026.
12. Zhao H. Synthetic Biology: Tools and Applications 2013, Academic Press.
13. Yu J.L., et al. Direct biosynthesis of adipic acid from a synthetic pathway in recombinant Escherichia coli. Biotechnol. Bioeng. 2014, 111:2580-2586.
14. Paddon C.J., et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 2013, 496:528-532.
15. Tsuruta H., et al. High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin in Escherichia coli. PLoS ONE 2009, 4:e4489.
16. Schmidt-Dannert C. Biosynthesis of terpenoid natural products in fungi. Adv. Biochem. Eng. Biotechnol. 2015, 148:19-61.
17. Wawrzyn G.T., et al. Discovery and characterization of terpenoid biosynthetic pathways of fungi. Methods Enzymol. 2012, 515:83-105.
18. Kelner M.J., et al. Preclinical evaluation of illudins as anticancer agents. Cancer Res. 1987, 47:3186-3189.
19. Wawrzyn G.T., et al. Draft genome of Omphalotus olearius provides a predictive framework for sesquiterpenoid natural product biosynthesis in basidiomycota. Chem. Biol. 2012, 19:772-783.
20. Shang R.F., et al. Synthesis and biological evaluation of new pleuromutilin derivatives as antibacterial agents. Molecules 2014, 19:19050-19065.
21. Shiao M.S. Triterpenoid natural-products in the fungus Ganoderma lucidum. J. Chin. Chem. Soc. 1992, 39:669-674.
22. Chen S., et al. Genome sequence of the model medicinal mushroom Ganoderma lucidum. Nat. Commun. 2012, 3:913.
23. Li G., et al. A highly efficient polyethylene glycol-mediated transformation method for mushrooms. FEMS Microbiol. Lett. 2006, 256:203-208.
24. Li S., et al. Efficient transformation of the medicinal mushroom Ganoderma lucidum. Plant Mol. Biol. Rep. 2001, 19:383.
25. Sun L., et al. PEG-mediated transformation of Lentinus edodes. Acta Bot. Sin. 2001, 43:1089-1092.
26. Kuo C.Y., Huang C.T. A reliable transformation method and heterologous expression of beta-glucuronidase in Lentinula edodes. J. Microbiol. Methods 2008, 72:111-115.
27. Chai R., et al. Beta-glucan synthase gene overexpression and beta-glucans overproduction in Pleurotus ostreatus using promoter swapping. PLoS ONE 2013, 8:e61693.
28. Lin Y.J., et al. Enhancement of heterologous gene expression in Flammulina velutipes using polycistronic vectors containing a viral 2A cleavage sequence. PLoS ONE 2013, 8:e59099.
29. Lugones L.G., et al. The SC15 protein of Schizophyllum commune mediates formation of aerial hyphae and attachment in the absence of the SC3 hydrophobin. Mol. Microbiol. 2004, 53:707-716.
30. Ohm R.A., et al. An efficient gene deletion procedure for the mushroom-forming basidiomycete Schizophyllum commune. World J. Microbiol. Biotechnol. 2010, 26:1919-1923.
31. De Jong J.F., et al. Inactivation of ku80 in the mushroom-forming fungus Schizophyllum commune increases the relative incidence of homologous recombination. FEMS Microbiol. Lett. 2010, 310:91-95.
32. Nakazawa T., et al. Efficient gene targeting in delta Cc.ku70 or delta Cc.lig4 mutants of the Agaricomycetes Coprinopsis cinerea. Fungal Genet. Biol. 2011, 48:939-946.
33. Godio R.P., et al. A squalene epoxidase is involved in biosynthesis of both the antitumor compound clavaric acid and sterols in the basidiomycete H. sublateritium. Chem. Biol. 2007, 14:1334-1346.
34. Papa I.A., et al. Increasing pleuromutilin activity of Clitopilus passeckerianus by chemical mutagenesis and improvement of production medium. Philipp. Agric. Sci. 2006, 89:20-33.
35. Benkortbi O., et al. Batch kinetics and modelling of pleuromutilin production by Pleurotus mutilis. Biochem. Eng. J. 2007, 36:14-18.
36. Zou X., et al. Fed-batch fermentation for pleuromutilin production by Pleurotus mutilis. Res. J. Biotechnol. 2012, 7:67-72.
37. Bailey A.M., et al. Methods of increasing yields of pleuromutilins 2013, Glaxo Group Limited & the University of Bristol, United Kingdom, US 20130017608 A1.
38. Wu G.S., et al. Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review. Exp. Opin. Investig. Drugs 2013, 22:981-992.
39. Fang Q.H., Zhong J.J. Two-stage culture process for improved production of ganoderic acid by liquid fermentation of higher fungus Ganoderma lucidum. Biotechnol. Prog. 2002, 18:51-54.
40. Tang Y.J., et al. Performance analyses of a pH-shift and DOT-shift integrated fed-batch fermentation process for the production of ganoderic acid and ganoderma polysaccharides by medicinal mushroom Ganoderma lucidum. Bioresour. Technol. 2009, 100:1852-1859.
41. Liang C.X., et al. Enhanced biosynthetic gene expressions and production of ganoderic acids in static liquid culture of Ganoderma lucidum under phenobarbital induction. Appl. Microbiol. Biotechnol. 2010, 86:1367-1374.
42. + on ganoderic acid biosynthesis in static liquid culture of Ganoderma lucidum via calcineurin signal transduction. Biotechnol. Bioeng. 2013, 110:1913-1923.
43. 2+ in static liquid cultivation of Ganoderma lucidum. Biotechnol. Bioeng. 2014, 111:2358-2365.
44. Xu Y.N., Zhong J.J. Impacts of calcium signal transduction on the fermentation production of antitumor ganoderic acids by medicinal mushroom Ganoderma lucidum. Biotechnol. Adv. 2012, 30:1301-1308.
45. Zhang W., Tang Y.J. A novel three-stage light irradiation strategy in the submerged fermentation of medicinal mushroom Ganoderma lucidum for the efficient production of ganoderic acid and ganoderma polysaccharides. Biotechnol. Prog. 2008, 24:1249-1261.
46. Zhou J.S., et al. Enhanced accumulation of individual ganoderic acids in a submerged culture of Ganoderma lucidum by the overexpression of squalene synthase gene. Biochem. Eng. J. 2014, 90:178-183.
47. Miettinen K., et al. The seco-iridoid pathway from Catharanthus roseus. Nat. Commun. 2014, 5:3606.
48. Mi J., et al. De novo production of the monoterpenoid geranic acid by metabolically engineered Pseudomonas putida. Microb. Cell Fact. 2014, 13:170.
49. Alonso-Gutierrez J., et al. Principal component analysis of proteomics (PCAP) as a tool to direct metabolic engineering. Metab. Eng. 2015, 28:123-133.
50. Paddon C.J., Keasling J.D. Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat. Rev. Microbiol. 2014, 12:355-367.
51. Hedl M., et al. Class II 3-hydroxy-3-methylglutaryl coenzyme A reductases. J. Bacteriol. 2004, 186:1927-1932.
52. Martin V.J.J., et al. The in vivo synthesis of plant sesquiterpenes by Escherichia coli. Biotechnol. Bioeng. 2001, 75:497-503.
53. Westfall P.J., et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E111-E118.
54. Zhou L.M., et al. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 2005, 45:1345-1359.
55. Zhou Y.J., et al. Modular pathway engineering of diterpenoid synthases and the mevalonic acid pathway for miltiradiene production. J. Am. Chem. Soc. 2012, 134:3234-3241.
56. Dai Z., et al. Production of miltiradiene by metabolically engineered Saccharomyces cerevisiae. Biotechnol. Bioeng. 2012, 109:2845-2853.
57. Guo J., et al. CYP76AH1 catalyzes turnover of miltiradiene in tanshinones biosynthesis and enables heterologous production of ferruginol in yeasts. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:12108-12113.
58. Dai Z.B., et al. Producing aglycons of ginsenosides in bakers' yeast. Sci. Rep. 2014, 4:3698.
59. Dai Z., et al. Metabolic engineering of Saccharomyces cerevisiae for production of ginsenosides. Metab. Eng. 2013, 20:146-156.
60. Yan X., et al. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Res. 2014, 24:770-773.
61. Wang P., et al. Production of bioactive ginsenosides Rh2 and Rg3 by metabolically engineered yeasts. Metab. Eng. 2015, 29:97-105.
62. Seki H., et al. Licorice beta-amyrin 11-oxidase, a cytochrome P450 with a key role in the biosynthesis of the triterpene sweetener glycyrrhizin. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14204-14209.
63. Moses T., et al. Combinatorial biosynthesis of sapogenins and saponins in Saccharomyces cerevisiae using a C-16 alpha hydroxylase from Bupleurum falcatum. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:1634-1639.
64. Chang J.J., et al. Integrating an algal beta-carotene hydroxylase gene into a designed carotenoid-biosynthesis pathway increases carotenoid production in yeast. Bioresour. Technol. 2015, 184:2-8.
65. Xie W.P., et al. Construction of a controllable beta-carotene biosynthetic pathway by decentralized assembly strategy in Saccharomyces cerevisiae. Biotechnol. Bioeng. 2014, 111:125-133.
66. Xie W.P., et al. Sequential control of biosynthetic pathways for balanced utilization of metabolic intermediates in Saccharomyces cerevisiae. Metab. Eng. 2015, 28:8-18.
67. Bao D., et al. Sequencing and comparative analysis of the straw mushroom (Volvariella volvacea) genome. PLoS ONE 2013, 8:e58294.
68. Morin E., et al. Genome sequence of the button mushroom Agaricus bisporus reveals mechanisms governing adaptation to a humic-rich ecological niche. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:17501-17506.
69. Ohm R.A., et al. Genome sequence of the model mushroom Schizophyllum commune. Nat. Biotechnol. 2010, 28:957-963.
70. Yap H.Y.Y., et al. The genome of the tiger milk mushroom Lignosus rhinocerotis, provides insights into the genetic basis of its medicinal properties. BMC Genomics 2014, 15:635.
71. Zhu Y.J., et al. Chromosome-level genome map provides insights into diverse defense mechanisms in the medicinal fungus Ganoderma sinense. Sci. Rep. 2015, 5:11087.
72. Bao Z.H., et al. Homology-integrated CRISPR-Cas (HI-CRISPR) system for one-step multigene disruption in Saccharomyces cerevisiae. ACS Synth. Biol. 2015, 4:585-594.
73. Cong L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
74. Zetsche B., et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 2015, 163:759-771.
75. Enyeart P.J., et al. Biotechnological applications of mobile group II introns and their reverse transcriptases: gene targeting RNA-seq, and non-coding RNA analysis. Mob. DNA 2014, 5:2.
76. Jaspers N.G., et al. Anti-tumour compounds Illudin S and Irofulven induce DNA lesions ignored by global repair and exclusively processed by transcription- and replication-coupled repair pathways. DNA Repair (Amst.) 2002, 1:1027-1038.
77. Chen H.P., et al. Four new sesquiterpenoids from fruiting bodies of the fungus Inonotus rickii. J. Asian Nat. Prod. Res. 2014, 16:581-586.
78. Ma K., et al. New benzoate derivatives and hirsutane type sesquiterpenoids with antimicrobial activity and cytotoxicity from the solid-state fermented rice by the medicinal mushroom Stereum hirsutum. Food Chem. 2014, 143:239-245.
79. Ishikawa N.K., et al. Antimicrobial cuparene-type sesquiterpenes, enokipodins C and D, from a mycelial culture of Flammulina velutipes. J. Nat. Prod. 2001, 64:932-934.
80. Wang Y.Q., et al. Bioactive sesquiterpenoids from the solid culture of the edible mushroom Flammulina velutipes growing on cooked rice. Food Chem. 2012, 132:1346-1353.
81. Kanokmedhakul S., et al. Cytotoxic sesquiterpenes from luminescent mushroom Neonothopanus nambi. Tetrahedron 2012, 68:8261-8266.
82. Hartley A.J., et al. Investigating pleuromutilin-producing Clitopilus species and related basidiomycetes. FEMS Microbiol. Lett. 2009, 297:24-30.
83. Shi X.W., et al. Secoscabronine M, a novel diterpenoid from the Chinese bitter mushroom Sarcodon scabrosus. Chirality 2012, 24:386-390.
84. Bai R., et al. Striatoids A-F, cyathane diterpenoids with neurotrophic activity from cultures of the fungus Cyathus striatus. J. Nat. Prod. 2015, 78:783-788.
85. Han J., et al. Anti-inflammatory and cytotoxic cyathane diterpenoids from the medicinal fungus Cyathus africanus. Fitoterapia 2013, 84:22-31.
86. Hirota M., et al. Anti-inflammatory compounds from the bitter mushroom Sarcodon scabrosus. Biosci. Biotechnol. Biochem. 2002, 66:179-184.
87. Xu J.W., et al. Biotechnological production and application of ganoderic acids. Appl. Microbiol. Biotechnol. 2010, 87:457-466.
88. Weng C.J., et al. The anti-invasive effect of lucidenic acids isolated from a new Ganoderma lucidum strain. Mol. Nutr. Food Res. 2007, 51:1472-1477.
89. Kim K.H., et al. Lanostane triterpenoids from the mushroom Naematoloma fasciculare. J. Nat. Prod. 2013, 76:845-851.
90. Ma K., et al. Ganoboninketals A-C, antiplasmodial 3,4-seco-27-norlanostane triterpenes from Ganoderma boninense Pat. J. Nat. Prod. 2014, 77:1847-1852.
91. Hien B.T., et al. Cattienoids A-C, three novel steroids from the mushroom Tomophagus cattienensis. Fitoterapia 2013, 91:125-127.